C-reactive protein, Neopterin and Beta2 microglobulin levels pre and post TB treatment in The Gambia

Abstract

Our findings suggest that activation markers, particularly CRP, may have a role in identifying good response to TB therapy regardless of the strain of infection and could be further developed as point-of-care tests. In addition, B2M levels may allow differentiation between Mtb and Maf-infected subjects.